News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

OncoArendi Therapeutics has entered into a global license agreement with Yale University

10 February 2015

Michał Sołowow invested in OncoArendi Therapeutics Sp. z o.o.

19 January 2015

Oncoarendi Therapeutics won over 25.5 million zloty

23 December 2014

OncoArendi receives a grant of over 7 mln PLN for its lead drug discovery program

14 July 2014

On June 2, 2014 OncoArendi received another grant for IP protection PL

2 June 2014

Invitation to tender

6 March 2014

Events & Presentations

R&D Day Presentation, 07.12.2022

7 December 2022

Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches – February 19-23, 2020 | Victoria, BC, Canada

27 February 2020

EFMC-ASMC’19 – September 1-5, 2019 | Athens, Greece

11 September 2019

ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA

4 September 2019

ATS- International Conference – Dallas, 17-22.05.2019

22 May 2019

EFMC – YMCS – Young Medicinal Chemist Symposium – Ljubljana 02-06.09.2018

17 September 2018
This site is registered on wpml.org as a development site.